---
figid: PMC6279568__nihms-1502250-f0005
figlink: /pmc/articles/PMC6279568/figure/F5/
number: F5
caption: Model of resistance to MET and MET/MAPK/ERK inhibition in DFCI358. A, At
  baseline, mutant MET in parental DFCI358 cells activates KRAS, which in turn amplifies
  downstream MAPK/ERK signaling resulting in enhanced transcription and release of
  EGFR ligands. B, Upon MET inhibition in parental DFCI358 cells, amplified KRAS sustains
  MAPK/ERK signaling via EGFR-ligand stimulated EGFR and other activated RTKs. C,
  Upon dual MET/MEK inhibition in KRAS amplified NS Control DFCI358 cells, cell viability
  is sustained by the PI3K/AKT pathway activated directly by amplified KRAS. D, With
  KRAS downregulation and MET inhibition in KRAS KD DFCI358 cells, resulting in diminished
  MAPK/ERK signaling, cell viability is sustained by the PI3K/AKT pathway activated
  by RTKs, such as IR/IGF1R, HER2 and EGFR.
pmcid: PMC6279568
papertitle: Amplification of wild type KRAS imparts resistance to crizotinib in MET
  exon 14 mutant non-small cell lung cancer.
reftext: Magda Bahcall, et al. Clin Cancer Res. 2018 Dec 1;24(23):5963-5976.
pmc_ranked_result_index: '19159'
pathway_score: 0.8915488
filename: nihms-1502250-f0005.jpg
figtitle: Resistance to MET and MET/MAPK/ERK inhibition in DFCI358
year: '2018'
organisms:
- Homo sapiens
ndex: 8ea3b519-df12-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6279568__nihms-1502250-f0005.html
  '@type': Dataset
  description: Model of resistance to MET and MET/MAPK/ERK inhibition in DFCI358.
    A, At baseline, mutant MET in parental DFCI358 cells activates KRAS, which in
    turn amplifies downstream MAPK/ERK signaling resulting in enhanced transcription
    and release of EGFR ligands. B, Upon MET inhibition in parental DFCI358 cells,
    amplified KRAS sustains MAPK/ERK signaling via EGFR-ligand stimulated EGFR and
    other activated RTKs. C, Upon dual MET/MEK inhibition in KRAS amplified NS Control
    DFCI358 cells, cell viability is sustained by the PI3K/AKT pathway activated directly
    by amplified KRAS. D, With KRAS downregulation and MET inhibition in KRAS KD DFCI358
    cells, resulting in diminished MAPK/ERK signaling, cell viability is sustained
    by the PI3K/AKT pathway activated by RTKs, such as IR/IGF1R, HER2 and EGFR.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - SHC1
  - SHC4
  - SHC3
  - HRAS
  - IRS1
  - EGFR
  - AREG
  - BTC
  - AKT3
  - HBEGF
  - EGF
  - EPGN
  - TGFA
  - MAPK1
  - ERBB2
  - ERBB3
  - MAPK12
  - NRAS
  - SART3
  - SHC2
  - KRAS
  - MAP2K2
  - MAP2K1
  - MET
  - EREG
  - MAPK3
  - MAPK9
  - MAPK10
  - MAPK13
  - AKT2
  - AKT1
  - MAPK14
  - MAPK11
  - MAPK8
  - STAT3
  - Cancer
  - Lung cancer
genes:
- word: IR/IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: HRAS
  symbol: HRAS
  source: hgnc_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: EGFR,
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: AREG
  entrez: '374'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: BTC
  entrez: '685'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EPGN
  entrez: '255324'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HER2/3
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HER2/3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EREG
  entrez: '2069'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MET/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC6279568__F5
redirect_from: /figures/PMC6279568__F5
figtype: Figure
---
